<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01600183</url>
  </required_header>
  <id_info>
    <org_study_id>UNFO-12-SOR-CTIL</org_study_id>
    <nct_id>NCT01600183</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)</brief_title>
  <official_title>Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unfo Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unfo Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, control, open label study in which up to 50 subjects with
      metatarsus adductus (MTA) will be enrolled. Subjects will be treated with the standard
      casting or using the UNFO-s device for total time of 20 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing of the MTA</measure>
    <time_frame>20 weeks</time_frame>
    <description>Healing of the MTA: straightening of the foot with apprx. 10% overcorrection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety of the UNFO-s device</measure>
    <time_frame>7 months</time_frame>
    <description>Safety is defined as absence of serious complications associated with the use of the investigational device within 2 month of the last visit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Metatarsus Adductus</condition>
  <condition>Metatarsus Varus</condition>
  <arm_group>
    <arm_group_label>casting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects with MTA will be treated with cast for 20 weeks. casting is replaced during every study visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UNFO-s</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects with MTA will be treated with the UNFO-s device for 12 weeks - will be worn day and night during first 6 weeks and only at night during next 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UNFO-s</intervention_name>
    <description>The UNFO-s is a foot orthosis used to treat congenital foot malformations in infants</description>
    <arm_group_label>UNFO-s</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cast</intervention_name>
    <description>casting of the infant legs</description>
    <arm_group_label>casting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with an acute MTA that did not receive any treatment for this condition

          -  Consenting parents

          -  Ages 1-4 months

        Exclusion Criteria:

          -  Participation in another clinical trial.

          -  Neuromuscular disorders

          -  Any condition which in the opinion of the investigator renders the subject ineligible
             for study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Atar, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soroka MC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan Atar, Prof</last_name>
    <phone>972-506264277</phone>
    <email>dan_atar@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Soroka MC</name>
      <address>
        <city>Beer Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dan Atar, Prof</last_name>
      <phone>972-50-6264277</phone>
      <email>dan_atar@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2012</study_first_posted>
  <last_update_submitted>May 15, 2012</last_update_submitted>
  <last_update_submitted_qc>May 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MTA</keyword>
  <keyword>metatarsus</keyword>
  <keyword>Metatarsus Adductus, also known as Metatarsus Varus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metatarsus Varus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

